# Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .

> **NCT05326841** · PHASE3 · COMPLETED · sponsor: **Dr Cipto Mangunkusumo General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Lupus Erythematosus, Systemic
- Cholecalciferol Supplementation
- Disease Activity
- Quality of Life

## Interventions

- **DRUG:** Vitamin D3

## Key facts

- **NCT ID:** NCT05326841
- **Lead sponsor:** Dr Cipto Mangunkusumo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-03
- **Primary completion:** 2022-01-11
- **Final completion:** 2022-01-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05326841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05326841, "Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05326841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*